Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy.

Limdi NA, Beasley TM, Allison DB, Rivers CA, Acton RT.

Blood Cells Mol Dis. 2006 Sep-Oct;37(2):100-6.

2.

Factor V Leiden as a common genetic risk factor for venous thromboembolism.

Horne MK 3rd, McCloskey DJ.

J Nurs Scholarsh. 2006;38(1):19-25. Review.

PMID:
16579319
3.

Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.

Price DT, Ridker PM.

Ann Intern Med. 1997 Nov 15;127(10):895-903. Review.

PMID:
9382368
4.

Epidemiology of factor V Leiden: clinical implications.

De Stefano V, Chiusolo P, Paciaroni K, Leone G.

Semin Thromb Hemost. 1998;24(4):367-79. Review.

PMID:
9763354
6.

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group..

Genet Med. 2011 Jan;13(1):67-76. doi: 10.1097/GIM.0b013e3181fbe46f.

PMID:
21150787

Supplemental Content

Support Center